Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
I'm Ready to Subscribe
Special Offers
DNBi. Leverage D&B's credit assessment tools.

CEL-SCI Corporation · Vienna, VA United States (NYSE Amex: CVM)

8229 Boone Blvd.,
Ste. 802
Phone: 703-506-9460
ViennaVAFax: 703-506-9471
22182
United StatesMap Map This Company
  • Company Profiles
  • Competitive Landscapes
  • Industry Reports

Buy Reports

For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now

CEL-SCI Corporation Rankings

Company Description

CEL-SCI hopes to make L.E.A.P.S. and bounds in preventing and treating deadly diseases. Its L.E.A.P.S. (Ligand Epitope Antigen Presentation System) technology modulates T-cells and may lead to synthetic vaccines for herpes, viral encephalitis, smallpox, and other diseases; the National Institutes of Health is testing CEL-1000 (a compound developed using L.E.A.P.S. technology) as a potential avian flu vaccine. The firm's lead drug candidate, however, is Multikine, which might make tumors more susceptible to radiation therapy and help a patient's body produce tumor-fighting antibodies. Multikine is undergoing clinical trials for the treatment of head and neck tumors.

To read the full description: Subscribe Now
left-headCEL-SCI Corporation Reports
right-head

No subscription, no problem.

Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Shop Reports
Shop Reports

Financials

Company TypePublic - NYSE Amex: CVM Headquarters
Fiscal Year-EndSeptember
2011 Employees44
More CEL-SCI Corporation Financials

Executives

12 executives listed for CEL-SCI Corporation's Vienna, VA location.

CEO, Treasurer, and DirectorGeert KerstenE-mail
President and DirectorMaximilian de ClaraE-mail
SVP Operations and SecretaryPatricia PrichepE-mail

More CEL-SCI Corporation Executives

Sponsored Links